The Ups and Downs of Nanobiotech

August 30, 2004 | Source: The Scientist

Ten years from now, a visit to the doctor could be quite different than it is today. How different? Imagine tiny particles that “cook” cancers from the inside out; “smart bomb” drugs that detonate only over their targets; and finely structured scaffolds that guide tissue regeneration.

Academic labs, small startups, and giant pharmaceutical companies are working to turn these proofs-of-principle into approved therapies.